Dopaminergic drug response and the genotype (Taq IA polymorphism) of the dopamine D2 receptor

International Journal of Neuropsychopharmacology

Volumn 3, Issue 1, 2000, Pages 35-43

  Berlin, Ivan ^a   De Brettes, Benoît ^a   Aymard, Guy ^a   Diquet, Bertrand ^a   Arnulf, Isabelle ^a   Puech, Alain J ^a,b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b SANOFI   (France)

Author keywords

Dopamine D2 receptor; Healthy subjects; Pharmacodynamic response; Taq IA polymorphism

Indexed keywords

APOMORPHINE; DNA; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; GROWTH HORMONE; TAQ POLYMERASE;

ARTICLE; BLOOD PRESSURE; BODY TEMPERATURE; CAUCASIAN; CONTROLLED STUDY; DNA POLYMORPHISM; DOSE RESPONSE; DROWSINESS; DRUG BLOOD LEVEL; DRUG DEPENDENCE; FEMALE; GENOTYPE; GROWTH HORMONE BLOOD LEVEL; HEART RATE; HUMAN; HUMAN EXPERIMENT; MALE; NAUSEA; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; PALLOR; PHARMACODYNAMICS; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SWEATING; VOMITING; YAWNING;

EID: 0034122252     PISSN: 14611457     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1461145700001711     Document Type: Article

References (39)

1. Altman J, Everitt BJ, Glautier S, Markou A, Nutt D, Oretti R, Phillips GD, Robbins TW (1996). The biological, social and clinical bases of drug addiction: commentary and debate. Psychopharmacology 125, 285-345.
2. American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Disorders (4th edn). Washington, DC: American Psychiatric Association.
3. Balldin J, Alling C, Gottfries CG, Lindstedt G Langström G (1985). Changes in dopamine receptor sensitivity in humans after heavy alcohol intake. Psychopharmacology 86, 142-146.
4. Balldin JA, Berggren UC, Lindstedt G (1992). Neuroendocrine evidence for reduced dopamine receptor sensitivity in alcoholism. Alcoholism: Clinical and Experimental Research 16, 71-74.
5. Balldin JA, Berggren UC, Lindstedt G, Sundkler A (1993). Further neuroendocrine evidence for reduced D2 dopamine receptor function in alcoholism. Drug and Alcohol Dependence 32, 159-162.
6. Blin O, Danjou P, Warot D, Fondarai J, Puech AJ (1988). Induction of yawning by low doses of apomorphine (0.1, 0.2, and 0.4 mg) in healthy volunteers. Psychiatry and Psychobiology 3, 195-199.
7. Blin O, Masson G, Azulay JP, Fondarai J, Serratrice G (1990). Apomorphine-induced blinking and yawning in healthy volunteers. British Journal of Clinical Pharmacology 30, 769-773.
8. Blum K, Noble EP, Sheridan PJ, Montgomery A, Ritchie T, Jagadeeswaran P, Nogami H, Brigge AH, Cohn JB (1990). Allelic association of human dopamine D2 receptor gene in alcoholism. Journal of the American Medical Association 263, 2055-2060.
9. Bolos AM, Dean M, Lucas-Derse S, Ramsburg M, Brown GL, Goldman D (1990). Population and pedigree studies reveal a lack of association between the D2 dopamine receptor and alcoholism. Journal of the American Medical Association 264, 3156-3160.
10. Comings DE, Muhleman D, Ahn C, Gysin R, Flanagan SD (1994). The dopamine D2 receptor gene: a genetic risk factor in substance abuse. Drug and Alcohol Dependence 34, 175-180.
11. Ettigi P, Lal S, Martin JB, Friesen HG (1975). Effect of sex, oral contraceptives, and glucose loading on apomorphine-induced growth hormone secretion. Journal of Clinical Endocrinology and Metabolism 40, 1094-1098.
12. Fabbrini G, Braun A, Mouradian MM, Jammings CA, Chase TN (1988). Dopamine D1 receptor agonist stimulation of prolactine secretion in man. Journal of Neural Transmission 71, 159-163.
13. Farren CK, Clare AW, Ziedonis D, Hammeedi FA, Ginan TG (1995). Evidence for reduced dopamine D2 receptor sensitivity in postwithdrawal alcoholics. Alcoholism: Clinical and Experimental Research 19, 1520-1524.
14. Finckh U, Rommelspacher H, Kuhn S, Dufeu P, Otto G, Heinz A, Dettling M, Giraldo-Velasquez M, Pelz J, Gräf K-J, Harms H, Sander T, Schmidt LG, Rolfs A (1997). Influence of the dopamine D2 receptor (DRD2) genotype on neuroadaptive effects of alcohol and the clinical outcome of alcoholism. Pharmacogenetics 7, 271-281.
15. Gelernter J, Kranzler H, Satel SL (1999). No association between D2 dopamine receptor (DRD2) alleles or haplotypes and cocaine dependence or severity of cocaine dependence in European- and African-Americans. Biological Psychiatry 45, 340-345.
16. Gelernter J, O'Malley S, Risch N, Kranzler HR, Krystal J, Merikangas K, Kennedy JL, Kidd KK (1991). No association between an allele at the D2 dopamine receptor gene (DRD2) and alcoholism. Journal of the American Medical Association 266, 1801-1807.
17. Grandy DK Zhang Y, Civelli O (1993). PCR detection of the Taq A RFLP at the DRD2 locus. Human Molecular Genetics 2, 2197.
18. Heinz A, Sander T, Harms H, Finckh U, Kuhn S, Dufeu P, Dettling M, Gräf K-J, Rolfs A, Rommelspacher H, Schmidt LG (1996). Lack of allelic association of dopamine D1 and D2 (TaqIA) receptor gene polymorphisms with reduced dopaminergic sensitivity to alcoholism. Alcoholism: Clinical and Experimental Research 20, 1109-1113.
19. Hollander E, Nunes E, DeCaria CM, Quitkin FM, Cooper T, Wager S, Klein DF (1990). Dopaminergic sensitivity and cocaine abuse: response to apomorphine. Psychiatry Research 33, 161-169.
20. Kidd KK, Pakstis AJ, Castiglione CM, Kidd JR, Speed WC, Goldman D, Knowler WC, Lu RB, Bonne-Tamir B (1996). DRD2 haplotypes containing the TaqI A1 allele: implications for alcoholism research. Alcoholism: Clinical and Experimental Research 20, 697-705.
21. Lal S, De la Vega CE, Sourkes TL, Friesen HG (1973). Effect of apomorphine on growth hormone, prolactin, luteinizing hormone and follicle-stimulating hormone levels in human serum. Journal of Clinical Endocrinology and Metabolism 37, 719-724.
22. Lal S, Martin JB, De La Vega C, Friesen HG (1975). Comparison of the effect of apomorphine and L-Dopa on serum growth hormone levels in normal men. Clinical Endocrinology 4, 277-285.
23. Lal S, Nair NPV, Iskandar HL, Etienne P, Wood PL, Schwartz G, Guyda H (1982). Effect of domperidone on apomorphine-induced growth hormone secretion in normal men. Journal of Neural Transmission 54, 277-285.
24. Lawford BR, Young RM, Rowell JA, Qualichefski J, Fletcher BH, Syndulko K, Ritchie T, Noble EP (1995). Bromocriptine in the treatment of alcoholics with the D2 dopamine receptor A1 allele. Nature Medicine 1, 337-341.
25. Noble EP (1996). Alcoholism and the dopaminergic system: a review. Addiction Biology 1, 333-348.
26. Noble EP, Blum K, Khalsa ME, Ritchie T, Montgomery A, Wood RC, Fitch RJ, Ozkaragos T, Sheridan PJ, Anglin MD, Paredes A, Treiman LJ, Sparkes RS (1993). Allelic association of the D2 dopamine receptor gene with cocaine dependence. Drug and Alcohol Dependence 33, 271-285.
27. Noble EP, Blum K, Ritchie T, Montgomery A, Sheridan PJ (1991). Allelic association of the D2 dopamine receptor gene with receptor-binding characteristics in alcoholism. Archives of General Psychiatry 48, 648-654.
28. Noble EP, St Jeor SJ, Ritchie T, Syndulko K, St Jeor SC, Fitch RJ, Brunner RL, Sparkes RS (1994). D2 dopamine receptor gene and cigarette smoking: a reward gene? Medical Hypotheses 42, 257-260.
29. Puech AJ, Simon P, Chermat R, Boissier J-R (1974). Profil neuropsychopharmacologique de l'apomorphine. Journal of Pharmacology 5, 241-254.
30. Sam E, Jeanjean AP, Maloteaux JM, Verbeke N (1995). Apomorphine pharmacokinetics in Parkinsonism after intranasal and subcutaneous application. European Journal of Drug Metabolism and Pharmacokinetics 20, 27-33.
31. Schmidt L, Dettling M, Graef K-J, Heinz A, Kuhn S, Podschus J, Rommelspacher H (1996). Reduced dopaminergic function in alcoholics is related to severe dependence. Biological Psychiatry 39, 193-198.
32. Smith SS, O'Hara BF, Persico AM, Gorelick DA, Newlin DB, Vlahov D, Solomon L, Pickens R, Uhl GR (1992). Genetic vulnerability to drug abuse. The D2 dopamine receptor Taq IB1 restriction fragment length polymorphism appears more frequently in polysubstance abusers. Archives of General Psychiatry 49, 723-727.
33. Szetchman H, Cleghom JM, Brown GM, Kaplan RD, Franco S, Rosenthal K (1987). Sensitization and tolerance to apomorphine in men: yawning, growth hormone, nausea, and hyperthermia. Psychiatry Research 23, 245-255.
34. Verma A, Kuldarni SK (1993). Differential role of dopamine receptor subtypes in thermoregulation and stereotypic behavior in naive and reserpinized rats. Archives Internationales de Pharinacodynamie et de Therapie 324, 17-32.
35. Volkow ND, Wang GJ Fowler JS, Logan J, Gatley SJ, Hitzemann R, Chen AD, Dewey SL, Pappas N (1997). Decreased striatal dopaminergic responsiveness in detoxified cocaine dependent subjects. Nature 386, 830-833.
36. Volkow ND, Wang GJ, Fowler JS, Logan J, Hitzemann R, Ding YS, Shea C, Piscani K (1996). Decreases in dopamine receptors but not in dopamine transporters in alcoholics. Alcoholism: Clinical and Experimental Research 20, 1594-1598.
37. Wang GJ, Volkow ND, Fowler JS, Logan J, Abumrad NN, Hitzemann RJ, Pappas NS, Pascani K (1997). Dopamine D2 receptor availability in opiate-dependent subjects before and after naloxone-precipitated withdrawal. Neuropsychopharmacology 16, 174-82.
38. Wiesbeck GA, Mauerer C, Thome J, Jakob F, Boening J (1995). Alcohol dependence, family history, and D2 dopamine receptor function as neuroendocrinologically assessed with apomorphine. Drug and Acohol Dependence 40, 49-53.
39. Zar JH (1984). Biostatistical Analysis (2nd edn). Englewood Cliffs, NJ: Prentice-Hall.